Hai‐Yan Tu

机构：Jiangnan University, Anhui University of Science and Technology, Fudan University, Wenzhou Medical University, Fudan University Shanghai Cancer Center, Shandong Transportation Research Institute, Wuxi Fourth People's Hospital, Third People's Hospital of Hangzhou, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University · ORCID：0000-0001-7125-9878

发表论文 290 篇 · 总被引 6789 次 · h-index 37

代表论文

• Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer (2025 · New England Journal of Medicine · 被引 100)
• The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study (2025 · Annals of Oncology · 被引 9)
• Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1 (2025 · Annals of Oncology · 被引 6)
• Spatiotemporal evolution characteristics of inundation in multi-level subway stations and inter-station tunnels: A multi-stage quantitative model (2025 · Smart Underground Engineering · 被引 5)
• Combined Effects of Donepezil and Memantine on Behavioral and Psychological Symptoms, Cognitive Function, and Daily Living Abilities in Patients With Alzheimer’s Disease (2025 · British Journal of Hospital Medicine · 被引 4)